Suven Life Sciences secured a product patent in Canada

Last Updated : Apr 03 2018 | 10:50 AM IST

Suven Life Sciences announced the grant of one (1) product patent from Canada (2907620) corresponding to the New Chemical Entity (NCE) for the treatment of disorders associated with Neurodegenerative diseases and this Patent is valid through 2033.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Connect with us on WhatsApp

SRG Housing Finance gets upgradation in credit ratings for bank facilities

JSW Steel with Nu Metal submits bids for Essar Steel

MOIL update on achievements for FY 2017-18

Board of Centrum Capital approves sale of stake held in CentrumDirect

First Published: Apr 03 2018 | 10:41 AM IST

Explore News

Stock Market LIVE
Stocks to Watch Today
Market Today
Latest News LIVE
Indo Farm Equipment IPO Allotment
Punjab PCS 2025 notification
Holiday Calendar 2025
Ind vs Aus 5th Test Day 1 LIVE
IPO News
Business Standard at 50